Northeast Georgia Cancer Care

Athens, Georgia 30607

0 studies enrolling now · 10 studies all time

What they study most

Breast Cancer With Low to Intermediate HER2 Expression, Follicular Lymphoma, HER-2 Positive Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, Locally Recurrent Breast Cancer, Locally Recurrent or Metastatic Breast Cancer, Metastatic Breast Cancer, Multiple Myeloma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma

Studies at this site

• Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta) — Stopped early
• The BEACON Study (Breast Cancer Outcomes With NKTR-102) — Completed
• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence — Completed
• A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) — Completed
• PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score — Completed
• Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer — Completed
• Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer — Stopped early
• Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma — Stopped early
• Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer — Completed
• Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma — Stopped early